Chronic reduction in complex I function alters calcium signaling in SH-SY5Y neuroblastoma cells

Brain Research

Volumn 891, Issue 1-2, 2001, Pages 94-105

  Sherer, Todd B ^a   Trimmer, Patricia A ^b,c   Borland, Kate ^b,c   Parks, Janice K ^b,c   Bennett Jr , James P ^b,c   Tuttle, Jeremy B ^b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Calcium; Mitochondria; Reactive oxygen species; Rotenone

Indexed keywords

REACTIVE OXYGEN METABOLITE; ROTENONE;

ANIMAL CELL; ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL DEATH; COMPLEX FORMATION; ENZYME ACTIVITY; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NERVE DEGENERATION; NEUROBLASTOMA CELL; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY CHAIN;

ANIMALS; CALCIUM SIGNALING; CELL DEATH; ELECTRON TRANSPORT COMPLEX I; HUMANS; MITOCHONDRIA; MODELS, BIOLOGICAL; NADH, NADPH OXIDOREDUCTASES; NERVE DEGENERATION; NEUROBLASTOMA; PARKINSON DISEASE; REACTIVE OXYGEN SPECIES; ROTENONE; TUMOR CELLS, CULTURED; UNCOUPLING AGENTS;

EID: 0035830688     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)03203-0     Document Type: Article

References (46)

1. Pharmacological properties of the T-type calcium current of mouse spermatogenic cells
2. Possible mechanism of the potent vasoconstrictor actions of ryanodine on femoral arteries from spontaneously hypertensive rats
3. Permanent human parkinsonism due to I-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): Seven cases
4. Titrating the effects of mitochondrial complex I impairment in the cell physiology
5. Altered signal transduction in vascular smooth muscle cells of spontaneously hypertensive rats
6. Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson's-plus syndromes
7. Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease
8. Retrograde calcium signaling in C2C12 skeletal myocytes in response to mitochondrial genetic and metabolic stress: A novel mode of inter-organelle cross-talk
9. Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy
10. Mitochondrial respiratory chain activity in skeletal muscle from patients with Parkinson's disease
11. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease
12. Interaction among mitochondria, MAPKs, and NFκB in cellular models of Parkinson's disease
13. L-dihydroxyphenylalanine and complex I deficiency in Parkinson's disease brain
14. The 49-kDa subunit of NADH-ubiquinone oxidoreductase (complex I) is involved in the binding of piericidin and rotenone, two quinone-related inhibitors
15. Visualization of cyclosporin A and calcium sensitive cyclical mitochondrial depolarizations in cell culture
16. Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not substantia nigra
17. Intracellular calcium clearance in Purkinje cell somata from rat cerebellar slices
18. A FCCP-sensitive calcium store in bullfrog sympathetic neurons and its participation in stimulus-evoked changes in calcium
19. Mitochondrial dysfunction in Parkinson's disease
20. Modulation of calcium-activated chloride currents in rabbit portal vein smooth muscle by an inhibitor of mitochondrial calcium uptake
21. A new generation of calcium indicators with greatly improved fluorescence properties
22. Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease
23. Mitochondrial regulation of store-operated calcium signaling in T lymphocytes
24. Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta with Parkinson's disease
25. Calcium homeostasis in the agonist-sensitive internal store: Functional interactions between mitochondria and the ER measured in situ in intact cells
26. A role for calcium influx in the regulation of mitochondrial calcium in endothelial cells
27. A novel model of slowly progressive Parkinson's disease
28. Complex I, iron, and ferritin in Parkinson's disease substantia nigra
29. Oxygen-bridged dinuclear ruthenium amine complex specifically inhibits calcium uptake into mitochondria in vitro and in situ in single cardiac myocytes
30. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine
31. Three classes of inhibitors share a common binding domain in mitochondrial complex I (NADH:ubiquinone oxidoreductase)
32. Electron transport chain abnormalities in idiopathic Parkinson's disease
33. Electron transport chain defects in Alzheimer's disease
34. Privileged access to mitochondria of calcium influx through N-Methyl-D-Aspartate receptors
35. J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of a membrane potential
36. Regional heterogeneity of MtDNA heteroplasmy in parkinsonian brain
37. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF
38. Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease
39. Mitochondrial DNA-depleted neuroblastoma (Rho°) cells exhibit altered calcium signaling
40. Intracellular heterogeneity in mitochondrial membrane potential revealed by J-aggregate forming lipohilic cation JC-1
41. Origin and functional consequences of the complex I defect in Parkinson's disease
42. Mitochondria in neurodegenerative apoptosis: An opportunity for therapy
43. Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds
44. Abnormal mitochondrial morphology in sporatic Parkinson's and Alzheimer's cybrid cell lines
45. Mitochondria buffer physiological calcium loads in cultured rat dorsal root ganglion neurons
46. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked